Latest news
Scholar Rock drops Catalent facility from marketing application for muscle weakness drug - 1470 & 100.3 WMBD1470 & 100.3 WMBD · Sat, 08 Aug 2026 02:32:33 GMTScholar Rock drops Novo Nordisk facility from marketing application for muscle weakness drug - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 21:29:19 GMTScholar Rock Holdings Pulls Novo Nordisk Facility From Drug Application After FDA Flag -- Update - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 20:10:00 GMTFDA Accepts daraxonrasib Application for RAS-Mutant Pancreatic Cancer - The Clinical Trial VanguardThe Clinical Trial Vanguard · Thu, 06 Aug 2026 06:43:58 GMTPuluo Pharmaceutical (000739.SZ) announced that its subsidiary's new drug application for fulzeresib active pharmaceutical ingredient has been approved. - MoomooMoomoo · Thu, 06 Aug 2026 03:57:18 GMTHealth Canada backlog of generic drug applications doubled over past year - The Globe and MailThe Globe and Mail · Wed, 05 Aug 2026 19:05:55 GMTLee's Pharmaceutical Says Investigational New Drug Application For ADC Project ZK2401 Accepted By NMPA - TradingViewTradingView · Thu, 30 Jul 2026 15:53:04 GMTAbivax on Track for 2026-end New Drug Application for Ulcerative Colitis Drug - MoomooMoomoo · Thu, 30 Jul 2026 07:00:00 GMT